Picture of Tricida logo

TCDAQ Tricida News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Tricida Announces The Selection Of The Valor-CKD Trial For An Oral Presentation In The High-Impact Clinical Trials Session At ASN Kidney Week 2022

Oct 3 (Reuters) - Tricida Inc  TCDA.O :
    * TRICIDA ANNOUNCES THE SELECTION OF THE VALOR-CKD TRIAL FOR
AN
ORAL PRESENTATION IN THE HIGH-IMPACT CLINICAL TRIALS SESSION AT
ASN KIDNEY WEEK 2022

Source text for Eikon:  ID:nBw8p49j1a 
Further company coverage:  TCDA.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Tricida

See all news